{
  "@context": "aku-v2",
  "@type": "clinical",
  "@id": "wsmg:health-sciences/medicine/surgery/vascular/pathology/mesenteric-ischemia/aku-043",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-04T21:35:00.000Z",
    "modified": "2026-01-09T11:29:00.000Z",
    "contributors": [
      "copilot-agent",
      "medical-content-team",
      "critical-care-perspective"
    ],
    "confidence": 0.95,
    "status": "enhanced",
    "language": "en",
    "licenses": [
      "CC-BY-4.0"
    ]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/mesenteric-ischemia",
    "subdomain": "nomi",
    "type": "clinical-entity",
    "difficulty": "advanced",
    "importance": "critical",
    "isNativeDomain": true
  },
  "content": {
    "title": "Non-Occlusive Mesenteric Ischemia (NOMI): Comprehensive ICU Management",
    "summary": "NOMI represents 20-30% of acute mesenteric ischemia but carries the highest mortality (70-90%). It occurs without mechanical occlusion, instead resulting from splanchnic vasoconstriction in critically ill patients.",
    "etiology": {
      "primary_mechanism": "Splanchnic vasoconstriction due to low-flow states",
      "high_risk_settings": [
        "Post-cardiac surgery (especially CABG and valve procedures)",
        "Cardiogenic shock",
        "Septic shock with high vasopressor requirements",
        "Hemodialysis with ultrafiltration",
        "Major abdominal/aortic surgery",
        "Severe burns",
        "Hemorrhagic shock with resuscitation"
      ],
      "contributing_factors": [
        "High-dose vasopressors (norepinephrine, vasopressin)",
        "Hypotension and hypoperfusion",
        "Digitalis (enhances splanchnic vasoconstriction)",
        "Cocaine use",
        "Ergot derivatives"
      ]
    },
    "pathophysiology": {
      "mechanism": "Prolonged mesenteric vasoconstriction outlasts the precipitating event",
      "unique_features": [
        "Can persist even after hemodynamic optimization",
        "Often affects watershed areas preferentially",
        "May be patchy rather than involving entire vascular territory"
      ]
    },
    "clinical_features": {
      "presentation": "Often masked by underlying critical illness and sedation",
      "subtle_signs": [
        "Unexplained metabolic acidosis",
        "Rising lactate despite apparent hemodynamic stability",
        "Increasing vasopressor requirements",
        "Abdominal distension",
        "Feeding intolerance",
        "Bloody nasogastric output or melena"
      ],
      "classic_patient": "Post-cardiac surgery patient on day 2-5 with unexplained deterioration"
    },
    "diagnosis": {
      "imaging": {
        "cta_findings": "May show diffuse arterial narrowing ('string of sausages' sign), bowel wall thickening, but NO filling defect",
        "challenge": "Absence of occlusion can lead to false reassurance"
      },
      "angiography": "Characteristic pruning of mesenteric branches with slow flow"
    },
    "icu_management_protocol": {
      "hemodynamic_optimization": {
        "goal": "Optimize cardiac output rather than MAP alone",
        "actions": [
          "Inotropes preferred over vasopressors when possible",
          "Consider dobutamine for cardiac output enhancement",
          "Target MAP 65-70 mmHg with lowest vasopressor dose",
          "Adequate volume resuscitation before vasopressor escalation"
        ]
      },
      "vasopressor_management": {
        "principle": "Minimize splanchnic vasoconstriction",
        "considerations": [
          "Transition from norepinephrine to less vasoconstrictive agents if feasible",
          "Avoid vasopressin if possible (significant mesenteric constriction)",
          "Consider milrinone for inotropic support (less vasoconstriction)"
        ]
      },
      "pharmacological_interventions": {
        "papaverine": {
          "dose": "30-60 mg/hr via SMA catheter",
          "mechanism": "Direct smooth muscle relaxation",
          "limitation": "Requires interventional radiology, invasive monitoring"
        },
        "glucagon": {
          "dose": "1-5 mg IV",
          "mechanism": "Decreases mesenteric vascular resistance",
          "evidence": "Limited but may be tried as rescue therapy"
        },
        "prostaglandins": {
          "agent": "Alprostadil (PGE1)",
          "mechanism": "Vasodilation and platelet inhibition",
          "use": "Experimental, limited clinical data"
        }
      },
      "supportive_care": [
        "NPO with aggressive nasogastric decompression",
        "TPN if prolonged course anticipated",
        "Broad-spectrum antibiotics for bacterial translocation",
        "Serial lactate and abdominal exams"
      ],
      "surgical_indications": [
        "Peritonitis",
        "Pneumatosis or portal venous gas",
        "Clinical deterioration despite maximal medical therapy",
        "Free perforation"
      ]
    },
    "prognosis": {
      "mortality": "70-90% - highest of all mesenteric ischemia types",
      "factors_affecting_outcome": [
        "Time to recognition",
        "Underlying cardiac reserve",
        "Extent of bowel involvement",
        "Ability to wean vasopressors"
      ]
    },
    "prevention_strategies": [
      "Early enteral feeding in ICU patients when feasible",
      "Judicious vasopressor use with regular reassessment",
      "Adequate hemodynamic resuscitation before major surgery",
      "Monitoring for early signs in high-risk patients"
    ],
    "clinical_significance": "NOMI has the highest mortality of all mesenteric ischemia types and is often recognized late due to masking by critical illness - awareness and early intervention are key to improving outcomes",
    "statement": "Non-Occlusive Mesenteric Ischemia (NOMI): Comprehensive ICU Management is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Mesenteric-Ischemia that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Non-Occlusive Mesenteric Ischemia (NOMI): Comprehensive ICU Management helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Non-Occlusive Mesenteric Ischemia (NOMI): Comprehensive ICU Management include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Non-Occlusive Mesenteric Ischemia (NOMI): Comprehensive ICU Management."
    }
  },
  "relationships": {
    "skos:broader": [
      "wsmg:health-sciences/medicine/surgery/vascular/pathology/mesenteric-ischemia/aku-002"
    ],
    "skos:related": [
      "wsmg:health-sciences/medicine/surgery/vascular/pathology/mesenteric-ischemia/aku-008",
      "wsmg:health-sciences/medicine/surgery/vascular/pathology/mesenteric-ischemia/aku-019"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Non-Occlusive Mesenteric Ischemia (NOMI): Comprehensive ICU Management. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}